Pharmaceuticals · Pharmaceuticals: Major · NSE: AMBALALSA · data 2026-10-30
Ambalal Sarabhai Enterprises Limited
In plain words
Price: 30.0% below its 52-week high of ₹49.98.
Delivery: 53.5% of traded shares were kept for delivery over the last 10 sessions, against 62.5% over the last 60.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹206 cr |
| Net profit (last 12 months) | ₹14 cr |
| Sales growth, 3 years (yearly) | 5.9% |
| Profit growth, 3 years (yearly) | 15.9% |
Smart-money activity
5/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Too few delivery days to compare delivery % (0 of 10); shares delivered not comparable (0 of 12); 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Common questions
Is Ambalal Sarabhai Enterprises Limited debt-free?
Its latest reported debt-to-equity ratio is 0.36.
What is Ambalal Sarabhai Enterprises Limited's P/E ratio?
About 19.8, based on the last 12 months' earnings and a price of ₹34.99 (data 2026-10-30).
What is the 52-week high and low of Ambalal Sarabhai Enterprises Limited?
The 52-week high is ₹49.98 and the 52-week low is ₹30.15.
Similar companies
Jenburkt Pharmaceuticals Ltd (JENBURPH) · Medicamen Biotech Limited (MEDICAMEQ) · Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) · Accretion Pharmaceuticals Ltd. (ACCPL) · Nectar Lifesciences Ltd. (NECLIFE)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open AMBALALSA in NSE Scanner →